Vasomotor symptoms (tibolone 2.5 mg/d) · postmenopausal women with vasomotor symptoms
Tibolone probably leads to higher vasomotor symptoms (tibolone 2.5 mg/d) compared with combined HT (moderate certainty).
1 finding from 1 review
Intervention not reported
Live Birth Rate · Subfertile women undergoing in vitro maturation
The intervention showed no clear difference in live Birth Rate (low certainty).
1 finding from 1 review
Intervention not reported
Miscarriage Rate · Subfertile women undergoing in vitro maturation
The intervention showed no clear difference in miscarriage Rate (low certainty).
1 finding from 1 review
Intervention not reported
Clinical Pregnancy Rate · Subfertile women undergoing in vitro maturation
The intervention showed no clear difference in clinical Pregnancy Rate (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events and drug reactions · Subfertile women undergoing in vitro maturation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vasomotor SymptomsFrequency of hot flushes measured in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Outcomesa · women with menopausal symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vasomotor symptoms (vasomotor) · women with menopausal symptoms
1 finding from 1 review
Adverse effects · women with menopausal symptoms
It is very uncertain whether CHM changes adverse Effects compared with HT (very low certainty).
1 finding from 1 review
Vasomotor SymptomsSeverity of hot flushes measured in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Vasomotor SymptomsOverall scores of hot flushes in a diary (daily) · women with menopausal symptoms
1 finding from 1 review
Vasomotor SymptomsOverall scores of hot flushes in a diary (monthly) · women with menopausal symptoms
1 finding from 1 review
Vasomotor symptoms: night sweats · women with menopausal symptoms
2 findings from 1 review
Vasomotor Symptomsmeasured by the Kupperman Index (KI, monthly) · women with menopausal symptoms
1 finding from 1 review
Vasomotor symptoms (vasomotor) · women with menopausal symptoms
1 finding from 1 review
Adverse effects · women with menopausal symptoms
It is very uncertain whether chinese herbal medicine (CHM) changes adverse Effects compared with placebo (very low certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Transdermal beta‐estradiol patch showed no clear difference in frequency of hot flushes Beta‐estradiol patch 0.0375‐0.10 mg/day compared with placebo (low certainty).
1 finding from 1 review
Change in frequency of hot flushes from baseline to end of study · women with hot flushes
Intranasal beta‐estradiol showed no clear difference in frequency of hot flushes Change from baseline Intranasal… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects Intranasal beta‐estradiol 0.021 mg/day, 0.029 mg/day or 0.040 mg/day · women with hot flushes
Intranasal beta‐estradiol probably leads to higher adverse effects Intranasal beta‐estradiol 0.021 mg/day, 0.029 mg/day… compared with placebo (moderate certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
1 finding from 1 review